Bruno Quesnel

CNRS, Inserm, CHU Lille, UMR9020 UMR1277 Canther Cancer Heterogeneity, Plasticity And Resistance To Therapies, 1 Place De Verdun
Lille, 59000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries.

Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries.

Journal: JCO global oncology

Published: April 23, 2026

Chlorophenylpyrazolone derivatives as novel PD-L1-targeted inhibitors of the PD-1/PD-L1 immune checkpoint.

Chlorophenylpyrazolone derivatives as novel PD-L1-targeted inhibitors of the PD-1/PD-L1 immune checkpoint.

Journal: Bioorganic & medicinal chemistry letters

Published: February 27, 2026

Selective access to individual cells after assembling for advanced cell-cell interaction studies.

Selective access to individual cells after assembling for advanced cell-cell interaction studies.

Journal: Journal of nanobiotechnology

Published: September 15, 2025

Pre-therapeutic bone marrow-resident leukemic cells in acute myeloid leukemia exhibit a distinct dysregulated calcium signature and stem-like profile reflecting minimal residual disease precursors.

Pre-therapeutic bone marrow-resident leukemic cells in acute myeloid leukemia exhibit a distinct dysregulated calcium signature and stem-like profile reflecting minimal residual disease precursors.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 28, 2025

Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe.

Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe.

Journal: Cytotherapy

Published: May 30, 2025

Author Correction: Full-length RNA-Seq of the RHOH gene in human B cells reveals new exons and splicing patterns.

Author Correction: Full-length RNA-Seq of the RHOH gene in human B cells reveals new exons and splicing patterns.

Journal: Scientific reports

Published: April 28, 2025

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML.

Long-term follow-up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML.

Journal: HemaSphere

Published: January 02, 2025

Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia.

Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia.

Journal: Biological research

Published: April 27, 2024

Full-length RNA-Seq of the RHOH gene in human B cells reveals new exons and splicing patterns.

Full-length RNA-Seq of the RHOH gene in human B cells reveals new exons and splicing patterns.

Journal: Scientific reports

Published: March 19, 2024

Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.

Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.

Journal: Experimental hematology

Published: March 15, 2024

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.

Journal: HemaSphere

Published: January 29, 2024

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.

Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.

Journal: Blood advances

Published: December 12, 2023

Showing 1-12 of 113

Last Updated: 09/26/2026